Devin Wenig, Director at NASTECH PHARMACEUTICAL CO INC (NSTK), sold 3,000 shares at $14.20 ($44K) on 2007-11-01, disclosed to the SEC on 2007-11-02.
Scheduled sale ($44k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.20 | 1,000 | $14K | 32.6% |
| 2 | $14.41 | 100 | $1K | 3.3% |
| 3 | $14.42 | 400 | $6K | 13.2% |
| 4 | $14.70 | 133 | $2K | 4.5% |
| 5 | $14.71 | 200 | $3K | 6.7% |
| 6 | $14.73 | 167 |
| $2K |
| 5.6% |
| 7 | $14.85 | 1,000 | $15K | 34.0% |
| Total | $14.54 avg | 3,000 | $44K | 100% |
| Filing → |
| EBAY | SELL | 2019-07-03 | $398K | — | Filing → |
| EBAY | SELL | 2018-02-08 | $11.5M | — | Filing → |
| EBAY | SELL | 2013-10-31 | $2.4M | — | Filing → |